Last reviewed · How we verify
Combination (Bivalent) BNT162b2 and BNT162b2 OMI (combination-bivalent-bnt162b2-and-bnt162b2-omi)
Combination (Bivalent) BNT162b2 and BNT162b2 OMI (generic name: combination-bivalent-bnt162b2-and-bnt162b2-omi) is a vaccine drug developed by Pfizer. It is currently FDA-approved for Prevention of COVID-19 in individuals 12 years of age and older, Prevention of COVID-19 in individuals 5 years of age and older.
Pfizer's combination-bivalent-bnt162b2-and-bnt162b2-omi is a marketed COVID-19 vaccine developed by Pfizer Inc. It works by targeting the SARS-CoV-2 virus. The vaccine is indicated for individuals 12 years of age and older for prevention of COVID-19, and for individuals 5 years of age and older. This vaccine is clinically differentiated from others due to its combination of two bivalent components. It has achieved significant commercial success, generating $63.6B in revenue. There are no pipeline developments mentioned.
At a glance
| Generic name | combination-bivalent-bnt162b2-and-bnt162b2-omi |
|---|---|
| Sponsor | Pfizer |
| Drug class | vaccine |
| Target | SARS-CoV-2 virus |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Prevention of COVID-19 in individuals 12 years of age and older
- Prevention of COVID-19 in individuals 5 years of age and older
Common side effects
- Injection site pain
- Fatigue
- Headache
- Pyrexia
- Myalgia
- Chills
- Lymphadenopathy
- Pain
- Pain in extremity
- Nausea
- Diarrhoea (DIARRHEA)
- Vomiting (VOMITING)
Drug interactions
- Warfarin
- Aspirin
- Pain medications (e.g., ibuprofen, naproxen)
- Anticoagulants (e.g., heparin, enoxaparin)
- Antiplatelet agents (e.g., clopidogrel, prasugrel)
- Thrombolytics (e.g., alteplase, tenecteplase)
- Live vaccines
- Immunosuppressants (e.g., corticosteroids, cyclosporine)
- Interferons (e.g., interferon-alpha, interferon-beta)
- Other vaccines
Key clinical trials
- To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. (PHASE3)
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza (PHASE2)
- A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). (PHASE2)
- COVID-19 Fourth Dose Study in Australia (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Combination (Bivalent) BNT162b2 and BNT162b2 OMI CI brief — competitive landscape report
- Combination (Bivalent) BNT162b2 and BNT162b2 OMI updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Combination (Bivalent) BNT162b2 and BNT162b2 OMI
What is Combination (Bivalent) BNT162b2 and BNT162b2 OMI?
What is Combination (Bivalent) BNT162b2 and BNT162b2 OMI used for?
Who makes Combination (Bivalent) BNT162b2 and BNT162b2 OMI?
What is the generic name of Combination (Bivalent) BNT162b2 and BNT162b2 OMI?
What drug class is Combination (Bivalent) BNT162b2 and BNT162b2 OMI in?
What development phase is Combination (Bivalent) BNT162b2 and BNT162b2 OMI in?
What are the side effects of Combination (Bivalent) BNT162b2 and BNT162b2 OMI?
What does Combination (Bivalent) BNT162b2 and BNT162b2 OMI target?
Related
- Drug class: All vaccine drugs
- Target: All drugs targeting SARS-CoV-2 virus
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of COVID-19 in individuals 12 years of age and older
- Indication: Drugs for Prevention of COVID-19 in individuals 5 years of age and older
- Compare: Combination (Bivalent) BNT162b2 and BNT162b2 OMI vs similar drugs
- Pricing: Combination (Bivalent) BNT162b2 and BNT162b2 OMI cost, discount & access